Team:USTC CHINA/Project/Results/FurthurWork
From 2013.igem.org
(Difference between revisions)
Line 70: | Line 70: | ||
<img src="https://static.igem.org/mediawiki/igem.org/2/2a/2013ustc-china_WB800Nxianlu.png"width="400" height="150" /> | <img src="https://static.igem.org/mediawiki/igem.org/2/2a/2013ustc-china_WB800Nxianlu.png"width="400" height="150" /> | ||
</div> | </div> | ||
- | <div class="rightbar"> | + | <div class="rightbar"></div> |
<div><p>Then, three kinds of recombinant antigen, TD1-HBsAg, TD1-PA, TD1-Ag85b, and recombinant immunologic adjuvant were designed. The earliest successful one TD1-LTB protein, can not only be observed clear stripes in SDS-PAGE, but also be proved according to HPLC-MS.</p></div> | <div><p>Then, three kinds of recombinant antigen, TD1-HBsAg, TD1-PA, TD1-Ag85b, and recombinant immunologic adjuvant were designed. The earliest successful one TD1-LTB protein, can not only be observed clear stripes in SDS-PAGE, but also be proved according to HPLC-MS.</p></div> | ||
<div class="port-sidebar-border"><h>Project</h></div> | <div class="port-sidebar-border"><h>Project</h></div> |
Revision as of 05:54, 26 September 2013